Supernus Pharmaceuticals | SUPN - DŁUG





DŁUG Zmiana Data
Abbott USD 12.94B 496M 2025-09
ANI Pharmaceuticals USD 617.04M 3.28M 2025-12
Aurora Cannabis CAD 100.34M 1.29M 2025-09
Bristol-Myers Squibb USD 51.04B 112M 2025-09
Canopy Growth CAD 259.33M 68.47M 2025-09
Cara Therapeutics USD 0 0 2025-03
Corcept Therapeutics USD 6.36M 247K 2025-09
Eisai JPY 236.67B 49.14B 2025-09
Eli Lilly USD 42.51B 2.6B 2025-09
Novo Nordisk DKK 118.72B 61.75B 2025-03
Pacira USD 372.19M 4.53M 2025-12
Perrigo USD 3.64B 7.2M 2025-09
Pfizer USD 60.85B 78M 2025-09
Supernus Pharmaceuticals USD 42.21M 10.44M 2025-09
United Therapeutics USD 200M 100M 2025-03
Xeris Pharmaceuticals USD 257.65M 431K 2025-09